Clearside Biomedical discontinues Xipere combination therapy for RVO based on SAPPHIRE data Nov. 6, 2018
International Stem Cell reports interim data from phase I study of ISC-hpNSC in Parkinson's Nov. 6, 2018
VX-659/tezacaftor/ivacaftor triple combination regimen shows safety and efficacy in phase II study Nov. 6, 2018
Goldfinch Bio compound targets TRPC5 for the treatment of focal segmental glomerulosclerosis Nov. 6, 2018
PK and PD analysis in rhesus macaques of intravaginal ring containing the antiretroviral MK-2048 Nov. 6, 2018
RSS